Item | Number | Survivin Acetylation | P | P300 (positive) | P |
Sex |
|
|
|
|
|
Male | 44 | 51.35 ± 1.27 |
| 36 |
|
Female | 11 | 49.79 ± 2.04 | 0.251 | 5 | 0.155 |
Age |
|
|
|
|
|
≥60 | 42 | 63.42 ± 2.45 |
| 34 |
|
<60 | 13 | 60.76 ± 1.56 | 0.138 | 7 | 0.434 |
TNM |
|
|
|
|
|
I Stage | 7 | 32.14 ± 1.54* |
| 2* |
|
II Stage | 32 | 50.75 ± 2.04** |
| 25** |
|
III Stage | 16 | 70.58 ± 3.34** | 0.012 | 14** | 0.021 |
Histodifferentiation |
|
|
|
|
|
well-D | 7 | 33.18 ± 1.52* |
| 3* |
|
Moderately-D | 40 | 50.64 ± 2.78** |
| 31** |
|
Poorly-D | 8 | 73.15 ± 3.46** | 0.004 | 7** | 0.018 |
Lymphatic metastasis |
|
|
|
|
|
Have | 14 | 66.76 ± 4.57* |
| 3* |
|
None | 41 | 44.31 ± 2.18** | 0.027 | 38** | 0.021 |